Kevin W. Cormier
Moncton, NB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Interactomes of Glycogen Synthase Kinase-3 Isoforms.
Journal: Journal of proteome research
Published: February 13, 2023
Targeting lysosome function causes selective cytotoxicity in VHL-inactivated renal cell carcinomas.
Journal: Carcinogenesis
Published: July 21, 2019
STF-62247 accumulates in lysosomes and blocks late stages of autophagy to selectively target von Hippel-Lindau-inactivated cells.
Journal: American journal of physiology. Cell physiology
Published: February 14, 2019
Recent advances in understanding the cellular roles of GSK-3.
Journal: F1000Research
Published: February 13, 2017
Quantitative proteomics to study a small molecule targeting the loss of von Hippel-Lindau in renal cell carcinomas.
Journal: International journal of cancer
Published: August 31, 2016
(1)H NMR metabolomics analysis of renal cell carcinoma cells: Effect of VHL inactivation on metabolism.
Journal: International journal of cancer
Published: April 20, 2015
Autophagy and cell death to target cancer cells: exploiting synthetic lethality as cancer therapies.
Autophagy and cell death to target cancer cells: exploiting synthetic lethality as cancer therapies.
Journal: Advances in experimental medicine and biology
Published: November 26, 2013
Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells.
Journal: Anti-cancer agents in medicinal chemistry
Published: July 26, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026